Mitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging-Related Diseases
Diabetes & Metabolism Journal
; : 315-324, 2023.
Article
en En
| WPRIM
| ID: wpr-1000253
Biblioteca responsable:
WPRO
ABSTRACT
Mitochondria are complex metabolic organelles with manifold pathophysiological implications in diabetes. Currently published mitochondrial-encoded peptides, which are expressed from the mitochondrial open reading frame of the 12S ribosomal RNA type-c (MOTS-c), 16S rRNA (humanin and short humanin like peptide 1-6 [SHLP1-6]), or small human mitochondrial open reading frame over serine tRNA (SHMOOSE) are associated with regulation of cellular metabolism and insulin action in age-related diseases, such as type 2 diabetes mellitus. This review focuses mainly on recent advances in MOTS-c research with regards to diabetes, including both type 1 and type 2. The emerging understanding of MOTS-c in diabetes may provide insight into the development of new therapies for diabetes and other age or senescence-related diseases.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
En
Revista:
Diabetes & Metabolism Journal
Año:
2023
Tipo del documento:
Article